Oshino Drugs Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2000.
2000 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Oshino Drugs Private Limited

Oshino Drugs Private Limited, a active private limited company, was established on 17 February 2000 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2000PTC103818. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.92 M.

It upholds a compliant status. Employing 1 professional, Its leadership includes Savita Rani (Additional Director), Vishal Gupta (Director). Past directors included Rajesh Kumar Verma, Payal Gupta. It holds ₹1.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C-240, Flat No. 107, 1St Floor Pandav Nagar, New Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2000PTC103818

  • Registration Number

    103818

  • Incorporation Date

    17 February 2000

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹1.92 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.92 M
  • Company Age 26 Year, 4 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.22 Cr
  • Revenue Growth **** 2.65%
  • Profit Growth **** 11.37%
  • Ebitda **** 8.30%
  • Net Worth 44.03%
  • Total Assets -9.96%
Company report

Oshino Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Oshino Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Oshino Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Savita Rani Additional Director 07 Jan 2010 Current
Vishal Gupta Director 01 Oct 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Aug 2007 Past
Pramod Abcsdd Director 07 Jan 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Oshino Drugs.

Oshino Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.65% increase. The company also saw a substantial improvement in profitability, with a 11.37% increase in profit. The company's net worth Soared by an impressive increase of 44.03%.

Oshino Drugs revenue growth over time
Oshino Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.65%
*******
*******
*******
*******
Revenue from Operations
*******
 2.65%
*******
*******
*******
*******
Total Assets
*******
 -9.96%
*******
*******
*******
*******
Profit or Loss
*******
 11.37%
*******
*******
*******
*******
Net Worth
*******
 44.03%
*******
*******
*******
*******
EBITDA
*******
 8.30%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Oshino Drugs?

Unlock access to Oshino Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,197,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.80 Cr
  • Canara Bank : 0.42 Cr
Latest Charge Details
Date Lender Amount Status
18 May 2024 Canara Bank ₹2.63 M Open
15 Sep 2018 Canara Bank ₹1.00 M Open
31 Jan 2014 Canara Bank ₹0.57 M Open
24 Sep 2010 Others ₹8.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Oshino Drugs?

Oshino Drugs has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Oshino Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oshino Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Oshino Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Oshino Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Oshino Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    A charge with Canara Bank amounted to Rs. 2.63 M with Charge ID 100932764 was registered on 18 May 2024. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 8.00 M registered on 24 Sep 2010 with Charge ID 10244272 was modified on 22 Dec 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100208785 was registered on 15 Sep 2018. was documented.

  • Charges

    A charge with Canara Bank amounted to Rs. 0.57 M with Charge ID 10496010 was registered on 31 Jan 2014. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Oshino Drugs Private Limited?

The CIN of Oshino Drugs Private Limited is U24239DL2000PTC103818.

Where is Oshino Drugs Private Limited headquartered?

Oshino Drugs Private Limited is headquartered at C-240, Flat No. 107, 1St Floor Pandav Nagar, New Delhi, Delhi, 110092.

When was Oshino Drugs Private Limited incorporated?

Oshino Drugs Private Limited was incorporated on 17 February 2000.

Who are the current directors of Oshino Drugs Private Limited?

The current directors of Oshino Drugs Private Limited are

What is the primary industry of Oshino Drugs Private Limited?

The primary industry of Oshino Drugs Private Limited is Manufacturing.

Is Oshino Drugs Private Limited a listed company?

Oshino Drugs Private Limited is unlisted.

What is the capital structure of Oshino Drugs Private Limited?

The authorized capital of Oshino Drugs Private Limited is ₹2.00 M, and the paid-up capital is ₹1.92 M.

What is the compliance status of Oshino Drugs Private Limited?

The compliance status of Oshino Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available